GOOD ASSETS
HEXCARE 7803 Share Price
RM0.06
klse: Hextar Healthcare Berhad
Stock Information
Board : Main
Shariah : Shariah Compliant
Sector : Gloves
Address: Lot 138201, Off 3/4 Mile, Jalan Bercham, Kawasan Perindustrian Bercham, 31400 Ipoh, Perak
Contact: +605-5482723
Website: https://hextarhealthcare.com//
Stock Background
Hextar Healthcare Bhd is an investment holding company. The Company engages in the manufacturing of natural rubber, synthetic rubber, and vinyl gloves for household, industrial, professional and food handling applications. Its products include Latex, Nitrile, Neoprene and Disposable gloves.
Profit Analysis: HEXCARE 7803
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 22/05/26 | 31,049 | -2,716 | -2,927 |
| 24/02/26 | 35,536 | -21,211 | -31,386 |
| 28/11/25 | 35,743 | -5,396 | -5,809 |
| 29/08/25 | 39,210 | -6,763 | -4,261 |
| 29/05/25 | 37,626 | -4,110 | -3,499 |
| 26/02/25 | 41,654 | -10,633 | -7,990 |
| 28/11/24 | 30,434 | -5,170 | -4,060 |
| 29/08/24 | 34,539 | -3,521 | -2,502 |
| 27/05/24 | 40,324 | 343 | 632 |
| 26/02/24 | 36,637 | -56,820 | -47,753 |
| 28/11/23 | 45,542 | -8,171 | -9,823 |
| 22/08/23 | 40,492 | -5,798 | -5,895 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 142 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | -44,383 |
| Last 4 Quarter EPS (sen) | -4.04 |
| Last 4 Quarter PER | 0 |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | 0.00 |
| Net Tangible Assets (RM) | 0.42 |
| Goodwill (RM) | 0 |
| Cash (RM’000) | 36,530 |
| Debt (RM’000) | 2,310 |
| Total Debt (RM’000) | 25,350 |
| Net Assets (RM’000) | 452,450 |
| Current Ratio | 5.82 |
| Quick Ratio | 3.88 |
| Cash Ratio | 1.60 |
Technical
Technical Analysis
| MACD (26 vs 12) | -1.788 |
|---|---|
| Exponential Moving Average 5 | 0.057 |
| Exponential Moving Average 20 | 0.056 |
| Exponential Moving Average 90 | 0.066 |
| Relative Strength Index 14 | 0.50 |
| Stochastic %D 3 | 0.33 |
| Stochastic %K 14 | 1.00 |
15 reviews for HEXCARE 7803
Show all Most Helpful Highest Rating Lowest Rating
Only logged in customers who have purchased this product may leave a review.
Stock Profit Analysis
-
BNASTRA 7195 ★★★★★RM2.14 - PETRONM 3042 ★★★★★RM3.44
- CMSB 2852 ★★★★★RM1.00
- SUNREIT 5176 ★★★★★RM2.23
Salary Proof
BURSA MALAYSIA –
Pretax profit in the current quarter decreased by RM6.6 million or 68.8% to RM3.0 million, from RM9.6 million in the fourth quarter of the previous year. Net of tax, Group profits decreased to RM2.6 million in the current quarter, a reduction of 72.0% from RM9.3 million in the previous quarter owing to the persistent easing of average selling prices for nitrile disposable gloves as well as slower order uptakes in the current quarter.
BURSA MALAYSIA –
Pretax profit in the current quarter decreased by RM21.9 million or 69.7% to RM9.5 million, from RM31.4 million in the third quarter. Net of tax, Group profits decreased to RM9.1 million in the current quarter, a reduction of 63.9% from RM25.2 million in the previous quarter owing to the continual easing of average selling prices (ASP), lower production efficiencies as well as slower order uptakes in the current quarter.
BURSA MALAYSIA –
Pretax profit in the current quarter increased by RM37.7 million or 50.8% from RM74.2 million in the fourth quarter of year 2020 to RM111.9 million in the current quarter ended 31 March 2021, on the back of strong market demand and higher sales volumes across the Group’s products namely household, industrial and nitrile disposable gloves. Net of tax, profits also soared to RM86.6 million in the current quarter, an increase of 45.8% from RM59.4 million in the previous quarter.
The Star –
Rubberex is among the companies to watch on Monday after their recent corporate announcements, TA Securities Research said. Rubberex’s net profit for the 3QFY20 surged 13 times to RM39.5mil from RM3.1mil a year ago, driven by higher nitrile glove demand.
BURSA MALAYSIA –
Pretax profit in the current quarter increased by RM20.7 million or 74.5% from RM27.8 million in the second quarter of the year to RM48.5 million in the current quarter ended 30 September 2020, on the back of strong market demand and an unprecedented increase in sales due to the pandemic. The most notable increase in revenue was derived from the Group’s nitrile disposable glove division as these gloves were deemed critical essential products for use by the healthcare and medical sectors in the fight against the pandemic.
The Star –
News of positive data from the Pfizer-BioNTech Covid-19 vaccine trial sent shares of glove manufacturers plunging in early trade Tuesday. Rubberex eased 13 sen, or 5.24% to RM2.35. The trigger was Pfizer’s announcement on Monday night that its vaccine jointly developed by the company and German partner BioNTech was 90% effective in preventing Covid-19 infections in ongoing Phase 3 trials.
The Star –
Glove manufacturers led the FBM KLCI higher on Monday as investors continued to chase the stocks amid rising Covid-19 cases. Rubberex added 38 sen to RM2.95.
The Edge –
Against the backdrop of resurgence of COVID-19 cases, the climb on Malaysian rubber glove stocks is regaining momentum. That the rubber glove manufacturers dominated the top gainers (in value) list says it all about the persistent buying interest. Rubberex Corp (M) Bhd, Hartalega Holdings Bhd, Supermax Corp Bhd, Comfort Glove Bhd, and Kossan Rubber Industries Bhd were among the top gainers this week.
BURSA MALAYSIA –
Pretax profit in the current quarter increased by 164.8% from RM10.5 million in the first quarter of the year to RM27.8 million in the current quarter ended 30 June 2020. The most notable increase in revenue was derived from the Group’s nitrile disposable glove division as these gloves were deemed critical essential products for use by the healthcare and medical sectors in the fight against the pandemic.
BURSA MALAYSIA –
Pretax profit in the current quarter increased by RM3.7 million or 54.4% from RM6.8 million in the fourth quarter of 2019 to RM10.5 million in the current quarter ended 31 March 2020, on the back of heightened demand and an unprecedented increase in sales due to the pandemic. The most notable increase in revenue was derived from the Group’s nitrile disposable glove division.
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 2.48 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 33.1 million and auditor’s remuneration of 276 thousands
INVESTING MALAYSIA –
12 MAR 20 – RHB Retail Research said Rubberex Corp (M) Bhd may rebound further after it tested the MYR0.79 support in recent sessions.
INVESTING MALAYSIA –
6 MAR 20 – Datuk Ong Choo Meng is now Rubberex Corp (M) Bhd’s largest shareholder with a 31.33% stake, just 1.67% shy of the 33% threshold that would trigger a mandatory general offer for the remaining shares he does not own in the company.
BURSA MALAYSIA –
Sales revenue for Q4 2019 decreased by RM7.6 million, from RM62.2 million in Q3 2019 to RM54.6 million, a reduction of 12.2%, as a result of lower overall sales due to competition and uncertainties over consumer spending towards the year-end. However, the Group was able to sustain its profitability through improvements in production efficiencies, favourable foreign exchange rates and product mix, resulting in gains and higher pretax profit of RM6.8 million in the current quarter, an improvement from RM3.7 million in the preceding quarter.
Investing Malaysia –
Average investing volume for Rubberex Corp. (M) Bhd in the past three months in stock market was 1433.3k lots
Investing Malaysia –
RUBEREX gets a score of 22.19 in our equity and assets quality test based on current share price of RM0.65
Investing Malaysia –
Rubberex Corp. (M) Bhd gets a score of 24.12 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 7803 in Bursa Malaysia declared adjusted 1.97% dividend yield in past few years
Investing Malaysia –
RUBEREX is estimated to have a profit consensus of 9.53 millions, with an adjusted market capitalization of 161.41 millions
REMUNERATION STUDY –
In Financial Year End 2018, the directors’ remuneration was 2.17 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 27.8 million and auditor’s remuneration of 256 thousands